Mettler-Toledo International (NYSE:MTD – Free Report) had its price target lifted by Barclays from $1,700.00 to $1,900.00 in a report published on Monday,Benzinga reports. Barclays currently has an overweight rating on the medical instruments supplier’s stock.
Several other research firms have also commented on MTD. Robert W. Baird raised their price target on shares of Mettler-Toledo International from $1,608.00 to $1,815.00 and gave the company a “neutral” rating in a research report on Monday. Wells Fargo & Company lifted their price objective on shares of Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the company an “equal weight” rating in a report on Monday, August 3rd. Weiss Ratings upgraded shares of Mettler-Toledo International from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, October 19th. Morgan Stanley increased their target price on shares of Mettler-Toledo International from $1,450.00 to $1,575.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 13th. Finally, UBS Group began coverage on shares of Mettler-Toledo International in a research note on Wednesday, September 9th. They set a “neutral” rating and a $1,460.00 target price on the stock. Six analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $1,595.77.
Mettler-Toledo International Trading Down 0.1%
Mettler-Toledo International stock opened at $1,750.03 on Monday. The company has a current ratio of 1.10, a quick ratio of 0.75 and a debt-to-equity ratio of 25.28. Mettler-Toledo International has a 12 month low of $1,023.05 and a 12 month high of $1,806.58. The stock’s 50 day simple moving average is $1,546.33 and its two-hundred day simple moving average is $1,350.82. The firm has a market cap of $34.81 billion, a PE ratio of 37.83, a P/E/G ratio of 3.49 and a beta of 1.16.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The medical instruments supplier reported $12.57 EPS for the quarter, topping analysts’ consensus estimates of $12.13 by $0.44. The business had revenue of $1.09 billion for the quarter, compared to analysts’ expectations of $1.07 billion. Mettler-Toledo International had a net margin of 22.25% and a return on equity of 15,012.71%. The business’s revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the company earned $11.15 EPS. Analysts anticipate that Mettler-Toledo International will post 47.83 earnings per share for the current year.
Insider Activity at Mettler-Toledo International
In other news, CEO Patrick Kaltenbach sold 942 shares of the stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $1,425.00, for a total transaction of $1,342,350.00. Following the transaction, the chief executive officer owned 4,480 shares in the company, valued at $6,384,000. This trade represents a 17.37% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Gerry Keller sold 435 shares of Mettler-Toledo International stock in a transaction on Monday, November 9th. The shares were sold at an average price of $1,734.05, for a total transaction of $754,311.75. Following the completion of the sale, the insider directly owned 259 shares in the company, valued at $449,118.95. This represents a 62.68% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.71% of the company’s stock.
Institutional Investors Weigh In On Mettler-Toledo International
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Edmond DE Rothschild Holding S.A. purchased a new position in Mettler-Toledo International during the second quarter valued at $26,000. Transamerica Financial Advisors LLC purchased a new stake in shares of Mettler-Toledo International during the second quarter worth about $32,000. Provenance Wealth Advisors LLC purchased a new stake in shares of Mettler-Toledo International during the third quarter worth about $54,000. Root Financial Partners LLC purchased a new stake in shares of Mettler-Toledo International during the third quarter worth about $56,000. Finally, Principia Wealth Advisory LLC raised its position in shares of Mettler-Toledo International by 2,050.0% during the 2nd quarter. Principia Wealth Advisory LLC now owns 43 shares of the medical instruments supplier’s stock worth $55,000 after purchasing an additional 41 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.
Mettler-Toledo International Company Profile
Mettler-Toledo International develops and manufactures precision instruments and systems used in laboratory, industrial, and retail settings. Its products include laboratory balances and analytical instruments, industrial scales and weighing systems, and equipment for measuring and monitoring production processes. The company also supplies product-inspection systems, including checkweighers, metal detectors, and X-ray inspection equipment, along with related software, installation, maintenance, and calibration services.
Further Reading
- Five stocks we like better than Mettler-Toledo International
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
